Lausanne-based Adaptyv raises €34.35 million Series A to build the automated lab for agentic biology
Adaptyv Bio, the Lausanne-based BioTech startup building an automated wet lab for AI-driven protein design, has raised a €34.35 million ($40 million) Series A round to expand its lab capacity and tackle harder biology problems. The round was led by Highland Europe, with existing investors Ace Ventur
<p>Adaptyv Bio, the Lausanne-based BioTech startup building an automated wet lab for AI-driven protein design, has raised a €34.35 million ($40 million) Series A round to expand its lab capacity and tackle harder biology problems. The round was led by Highland Europe, with existing investors Ace Ventur</p>